Advertisements



AstraZeneca"s Lumoxiti Gets FDA Nod for Hairy Cell Leukemia

Zacks.....»»

Category: topSource: redinewsSep 14th, 2018

Why This Hairy Cell Leukemia Treatment Could Be Big in Europe

Innate Pharma shares jumped on Thursday after the firm announced that the European Medicines Agency has accepted the Marketing Authorization Application for Lumoxiti for adult patients with relapsed........»»

Category: blogSource: 247wallstJan 2nd, 2020

AstraZeneca Receives FDA Approval For Rare B-Cell Lymphoma Drug Lumoxiti

AstraZeneca Receives FDA Approval For Rare B-Cell Lymphoma Drug Lumoxiti.....»»

Category: topSource: seekingalphaSep 18th, 2018

AstraZeneca says Calquence combination improved survival in leukemia patients

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 7th, 2019

AstraZeneca shares rise on early U.S. approval for leukemia drug

AstraZeneca shares rose 2.7% on Friday after the British drugmaker won earlier-than-expected U.S. regulatory approval for a leukemia drug, in a challenge to rival AbbVie ......»»

Category: topSource: reutersNov 22nd, 2019

AstraZeneca confirms FDA approval of lymphocytic leukemia treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 21st, 2019

AstraZeneca"s Drug Combo To Treat Non-Small Cell Lung Cancer Stumbles In Late-Stage Study

AstraZeneca plc (NYSE: AZN) faced a clinical setback in a study evaluating a combo drug regimen in non-small cell lung cancer, or NSCLC. read more.....»»

Category: blogSource: benzingaAug 21st, 2019

AstraZeneca"s Imfinzi Gains Orphan Drug Status for SCLC

The FDA assigns an orphan drug designation to AstraZeneca's (AZN) Imfinzi for the treatment of small cell lung cancer, the mo.....»»

Category: personnelSource: nytJul 12th, 2019

AstraZeneca"s Tagrisso Wins EU Nod for First-Line Lung Cancer

AstraZeneca's (AZN) Tagrisso gets an EU nod for first-line treatment of advanced or metastatic non-small cell lung cancer in patients with epidermal growth factor receptor (EGFR) m.....»»

Category: personnelSource: nytJun 11th, 2018

Novartis" CAR-T Therapy Kymriah Gets Approval in Europe

Novartis (NVS) gets EC approval for CAR-T therapy, Kymriah, for the treatment of pediatric and young adult patients up to 25 years of age with B-cell acute lymphoblastic leukemia. Novartis AG NVS announced that the European Commiss.....»»

Category: worldSource: nytAug 27th, 2018

Johns Hopkins All Children"s becomes first Florida pediatric hospital to have unique leukemia therapy

Johns Hopkins All Children’s Hospital is now the first pediatric hospital in Florida offering a cutting-edge cellular immunotherapy for advanced leukemia in children and young adults. It will be offering CAR-T Cell Gene Therapy for leukemia. Chimer.....»»

Category: topSource: bizjournalsAug 30th, 2018

FDA grants approval of HCL treatment Lumoxiti to AstraZeneca

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 13th, 2018

AstraZeneca says FDA approves LUMOXITI for certain patients

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 13th, 2018

Roth Capital remains bullish on Stemline after AstraZeneca"s Lumoxiti approved

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 14th, 2018

AstraZeneca's Lynparza shown to put brakes on ovarian cancer - Reuters

ReutersAstraZeneca's Lynparza shown to put brakes on ovarian cancerReutersMUNICH (Reuters) - An AstraZeneca drug that blocks a cancer cell's ability to repair its g.....»»

Category: topSource: googlenewsOct 22nd, 2018

Verastem Oncology Announces Collaboration With The Leukemia & Lymphoma Society To Accelerate Development Of Duvelisib For the Treatment Of Peripheral T-Cell Lymphoma

BOSTON, Mass.--(BUSINESS WIRE)-- Verastem, Inc. read more.....»»

Category: blogSource: benzingaNov 7th, 2018

Cancer journey caused me to reprioritize my life

I was supposed to start my residency in two and a half months. To describe it as shock or dismay was an understatement. Squamous cell carcinoma of the tongue was something cats get, not veterinarians in the early years of their career......»»

Category: topSource: bizjournalsMay 10th, 2024

Bloom Energy boosting Intel"s Santa Clara data center

Deal expected to make site the single largest fuel cell-powered high-performance computing data center in Silicon Valley......»»

Category: topSource: bizjournalsMay 10th, 2024

Boater dies just feet from land when he dives in to find cell phone, Florida cops say

Boater dies just feet from land when he dives in to find cell phone, Florida cops say.....»»

Category: topSource: yahooMay 10th, 2024

Pennsylvania to ban cell phone use while driving and require police to collect traffic stop data

Pennsylvania to ban cell phone use while driving and require police to collect traffic stop data.....»»

Category: topSource: yahooMay 9th, 2024

Bloom Energy Shares Climb After Q1 Results, Expanded Agreement With Intel

Bloom Energy announces a power capacity agreement with Intel that will result in Silicon Valley's largest fuel cell-powere.....»»

Category: blogSource: benzingaMay 9th, 2024